Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › LA › Hammond › NPI 1144227539
Hospital

North Oaks Medical Center, LLC

North Oaks Medical Center, LLC was paid $37.61M by Medicaid between Jan 2018 and Dec 2024, across 262 billing codes. Its largest line is 99285, emergency room visit (most serious) — 21% of everything it billed.

33Billing provider infoNORTH OAKS MEDICAL CENTER, LLC
HAMMOND, LA 70403
33aNPI1144227539assigned 06/30/2005
33bProvider typeRural Acute Care Hospital
28Total paid$37.61M
24GClaims1,144,071
24DCodes billed262
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Rural Acute Care Hospital providers in Louisiana

Rank by total paid#1 of 8
Median peer was paid$12.38M
This provider vs. median3.0×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official ANDERSON, MARK controls 11+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$500K$1.0M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018105,194$2.63M
2019116,321$3.27M
2020102,787$2.64M
2021167,054$4.87M
2022206,262$7.03M
2023257,341$8.96M
2024incomplete189,112$8.19M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 21% 53,787 47,640 $7.77M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 17% 59,845 54,244 $6.24M
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 8.6% 104,844 91,786 $3.24M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 8.2% 45,334 41,489 $3.07M
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 4.9% 19,212 15,650 $1.82M
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 2.9% 29,538 24,275 $1.08M
99282 Emergency department visit for the evaluation and management, low to moderate severity 2.8% 21,033 19,433 $1.05M
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 2.4% 30,895 26,954 $893K
96375 Therapeutic injection; each additional sequential IV push 2.3% 18,072 14,237 $854K
99281 Emergency department visit for the evaluation and management, self-limited or minor 2.0% 19,274 18,126 $754K
71045 Radiologic examination, chest; single view 1.5% 26,625 23,540 $568K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 1.5% 26,021 9,078 $548K
250 more codes
85025 Blood count; complete (CBC), automated, and automated differential WBC count 1.2% 88,087 $458K
80053 Comprehensive metabolic panel 1.2% 64,208 $448K
70450 Computed tomography, head or brain; without contrast material 1.2% 4,187 $442K
69436 Tympanostomy (requiring insertion of ventilating tube), general anesthesia 1.1% 2,426 $416K
20610 1.0% 3,488 $392K
62323 <1% 1,262 $349K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 14,352 $335K
87632 <1% 2,198 $308K
64493 <1% 567 $303K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 6,359 $281K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 4,099 $270K
31237 <1% 1,123 $253K
99214 Doctor's office visit, returning patient (more involved) <1% 5,264 $251K
36415 Collection of venous blood by venipuncture <1% 111,398 $237K
74177 Computed tomography, abdomen and pelvis; with contrast material <1% 734 $212K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 8,945 $200K
42830 <1% 356 $193K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 3,057 $179K
81025 <1% 25,745 $148K
87631 <1% 1,048 $140K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 376 $137K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 4,229 $126K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 1,452 $113K
84484 <1% 15,807 $113K
G0378 Hospital observation service, per hour <1% 922 $110K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 658 $104K
81001 <1% 47,406 $103K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 2,038 $101K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 376 $99K
73560 <1% 2,582 $87K
73610 <1% 2,011 $81K
73630 <1% 1,577 $76K
95886 <1% 336 $76K
64494 <1% 880 $70K
20611 <1% 268 $68K
20550 <1% 641 $64K
80048 Basic metabolic panel (calcium, ionized) <1% 11,082 $63K
27096 <1% 92 $63K
72100 <1% 1,226 $62K
71046 Radiologic examination, chest; 2 views <1% 2,369 $62K
64635 <1% 83 $59K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 1,977 $55K
83880 <1% 2,760 $55K
80061 Lipid panel <1% 4,937 $54K
83690 <1% 9,926 $49K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 1,304 $49K
83735 <1% 12,147 $49K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 2,636 $49K
A9579 Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml <1% 693 $48K
84443 Thyroid stimulating hormone (TSH) <1% 3,322 $48K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 190 $48K
20526 <1% 283 $44K
G2066 Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results <1% 318 $44K
31231 <1% 119 $43K
62321 <1% 157 $42K
73030 <1% 1,004 $37K
82553 <1% 7,225 $37K
75574 <1% 238 $37K
82550 <1% 9,361 $36K
J1050 Injection, medroxyprogesterone acetate, 1 mg <1% 1,388 $33K
83036 Hemoglobin; glycosylated (A1C) <1% 4,320 $32K
73130 <1% 722 $31K
C1769 Guide wire <1% 127 $31K
J0185 Injection, aprepitant, 1 mg <1% 105 $30K
99203 Doctor's office visit, new patient (routine) <1% 1,000 $30K
69210 <1% 866 $29K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 1,045 $29K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 357 $29K
64721 <1% 167 $29K
94060 <1% 520 $29K
83970 <1% 1,700 $29K
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg <1% 6,400 $28K
73564 <1% 544 $28K
72040 <1% 621 $27K
31575 <1% 106 $26K
97161 <1% 461 $25K
84439 <1% 2,832 $23K
G0260 Injection procedure for sacroiliac joint; provision of anesthetic, steroid and/or other therapeutic agent, with or without arthrography <1% 93 $22K
80076 <1% 3,956 $22K
87088 <1% 3,346 $21K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 885 $20K
83605 <1% 2,858 $19K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 12,237 $19K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 1,384 $19K
64636 <1% 139 $19K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 1,490 $19K
76830 Ultrasound, transvaginal <1% 205 $18K
94729 <1% 555 $18K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder <1% 489 $17K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 127 $16K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 4,574 $15K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring <1% 81 $14K
36591 <1% 295 $12K
82565 <1% 3,134 $12K
94726 <1% 168 $12K
92567 <1% 1,103 $11K
85730 <1% 3,447 $11K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 141 $11K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 43 $11K
92587 <1% 299 $11K
71250 <1% 148 $11K
85610 <1% 3,963 $10K
42820 Tonsillectomy and adenoidectomy; younger than age 12 <1% 71 $9K
93017 <1% 85 $9K
73502 <1% 170 $8K
81003 <1% 5,287 $8K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 267 $8K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 265 $8K
84100 <1% 3,256 $8K
95909 <1% 51 $8K
J2003 Injection, lidocaine hydrochloride, 1 mg <1% 765 $8K
80305 <1% 631 $7K
76801 <1% 106 $7K
77067 Screening mammography, bilateral, including computer-aided detection <1% 180 $7K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 255 $7K
84460 <1% 1,310 $7K
J0585 Injection, onabotulinumtoxina, 1 unit <1% 77 $6K
84450 <1% 1,298 $6K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 481 $6K
82077 <1% 692 $6K
80050 General health panel <1% 145 $6K
J3490 Unclassified drugs <1% 2,665 $6K
82570 <1% 2,277 $6K
95806 <1% 79 $5K
86140 <1% 1,599 $5K
82728 <1% 463 $5K
J2469 Injection, palonosetron hcl, 25 mcg <1% 206 $5K
82947 <1% 1,347 $5K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 5,227 $5K
84466 <1% 580 $5K
84550 <1% 2,221 $5K
76819 Fetal biophysical profile; without non-stress testing <1% 69 $5K
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units <1% 1,266 $4K
41899 Unlisted procedure, dentoalveolar structures <1% 13 $4K
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg <1% 2,772 $4K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) <1% 16 $4K
84156 <1% 2,170 $4K
72141 <1% 12 $4K
82962 <1% 3,928 $4K
96361 Intravenous infusion, hydration; each additional hour <1% 234 $4K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 34,192 $4K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 81 $4K
73620 <1% 88 $4K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up <1% 69 $3K
73600 <1% 86 $3K
95911 <1% 14 $3K
87641 <1% 114 $3K
70551 Magnetic resonance imaging, brain; without contrast material <1% 17 $3K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 136 $3K
84520 <1% 762 $3K
77063 Screening digital breast tomosynthesis, bilateral <1% 180 $3K
94618 <1% 124 $3K
85027 <1% 694 $3K
83540 <1% 670 $3K
74170 <1% 12 $3K
96417 <1% 21 $2K
86160 <1% 374 $2K
93296 <1% 390 $2K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 2,853 $2K
20605 <1% 13 $2K
85055 <1% 101 $2K
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser <1% 57 $2K
72125 Computed tomography, cervical spine; without contrast material <1% 14 $2K
J2360 Injection, orphenadrine citrate, up to 60 mg <1% 119 $2K
86038 <1% 185 $2K
90686 <1% 357 $2K
73110 <1% 58 $2K
J3475 Injection, magnesium sulfate, per 500 mg <1% 194 $2K
70360 <1% 63 $2K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 1,935 $2K
92557 <1% 27 $2K
84703 <1% 284 $2K
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml <1% 2,129 $2K
96376 <1% 29 $1K
J0134 Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg <1% 1,097 $1K
86200 <1% 128 $1K
64495 <1% 23 $1K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 32 $1K
86255 <1% 127 $1K
J2270 Injection, morphine sulfate, up to 10 mg <1% 375 $1K
31000 <1% 77 $1K
90677 <1% 18 $1K
J1644 Injection, heparin sodium, per 1000 units <1% 81 $1K
84145 <1% 73 $1K
J7510 Prednisolone oral, per 5 mg <1% 679 $1K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 55 $996.74
80320 <1% 84 $941.54
99215 Doctor's office visit, returning patient (complex) <1% 14 $745.99
85379 <1% 98 $709.22
J2704 Injection, propofol, 10 mg <1% 6,982 $656.62
87040 <1% 124 $626.55
86430 <1% 121 $583.04
86803 <1% 47 $577.47
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 261 $573.52
82150 <1% 123 $557.56
85652 <1% 268 $540.35
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 111 $512.25
J1040 Injection, methylprednisolone acetate, 80 mg <1% 259 $470.64
86235 <1% 33 $429.57
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 68 $415.19
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 269 $396.71
C1887 Catheter, guiding (may include infusion/perfusion capability) <1% 14 $394.67
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 205 $386.81
87186 <1% 70 $371.42
82043 <1% 80 $315.96
J1170 Injection, hydromorphone, up to 4 mg <1% 155 $307.30
84481 <1% 29 $279.34
99407 <1% 364 $261.19
59430 <1% 12 $209.02
90688 <1% 148 $207.80
87420 <1% 15 $204.06
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 177 $202.42
87077 <1% 28 $199.53
84702 <1% 24 $196.25
90656 <1% 37 $181.64
83615 <1% 34 $134.03
93298 <1% 12 $128.76
87210 <1% 26 $110.88
J0690 Injection, cefazolin sodium, 500 mg <1% 461 $87.50
84134 <1% 13 $82.84
J0780 Injection, prochlorperazine, up to 10 mg <1% 12 $76.60
92014 Ophthalmological services: medical examination and evaluation, comprehensive, established patient <1% 97 $74.88
85046 <1% 13 $73.07
86850 <1% 14 $68.44
82951 <1% 14 $65.65
J2175 Injection, meperidine hydrochloride, per 100 mg <1% 31 $58.86
85045 <1% 12 $53.64
J8540 Dexamethasone, oral, 0.25 mg <1% 13 $50.72
J1630 Injection, haloperidol, up to 5 mg <1% 16 $46.99
86901 <1% 14 $30.38
86900 <1% 14 $30.38
99406 <1% 42 $27.88
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 17 $22.33
J2060 Injection, lorazepam, 2 mg <1% 14 $20.67
82952 <1% 14 $20.00
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg <1% 14 $9.55
G0463 Hospital outpatient clinic visit for assessment and management of a patient 0% 11,793 $0.00
88305 Level IV - Surgical pathology, gross and microscopic examination 0% 815 $0.00
A9270 Non-covered item or service 0% 535 $0.00
G0008 Administration of influenza virus vaccine 0% 111 $0.00
74420 0% 19 $0.00
88304 0% 241 $0.00
00000 0% 326 $0.00
51798 0% 37 $0.00
Q4186 Epifix, per square centimeter (add-on, list separately in addition to primary procedure) 0% 16 $0.00
88312 0% 338 $0.00
Q0244 Injection, casirivimab and imdevimab, 1200 mg 0% 82 $0.00
02414 0% 33 $0.00
92012 Ophthalmological services: medical examination and evaluation, intermediate, established patient 0% 20 $0.00
J0171 Injection, adrenalin, epinephrine, 0.1 mg 0% 13 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialANDERSON, MARK (CHIEF FINANCIAL OFFICER)
Same official

Other billing entities under ANDERSON, MARK

Full network →
ProviderLocationPaid
North Oaks Medical Center, LLCHammond, LA$18.22M
ST. Francis Medical Group, LLCGreenwood, IN$9.92M
North Oaks Physician Group, LLCHammond, LA$7.29M
North Oaks Medical Center, LLCHammond, LA$4.17M
Spokane School District #81Spokane, WA$3.82M
North Oaks Physician Group, LLCHammond, LA$1.67M
North Oaks Medical Center, LLCHammond, LA$1.59M
R Hutto Od PLLCBaytown, TX$199K
Mountain Land Performance LCBillings, MT$32K
Anderson Jore Counseling PC.Grand Rapids, MN$20K
University Gastroenterology, PCKnoxville, TN$17K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.